Domov › Kolorektalni rak › Utah › Salt Lake City
Klinične študije za Kolorektalni rak v Salt Lake City, UT
22 študij za Kolorektalni rak išče udeležence na lokacijah v Salt Lake City in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
Vključevanje udeležencevFaza 1
- Huntsman Cancer Institute, Salt Lake City
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
Vključevanje udeležencev
- University of Utah, Salt Lake City
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
Vključevanje udeležencevFaza 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Vključevanje udeležencevFaza 2/3
- Local Institution - 0426, Salt Lake City
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Vključevanje udeležencevFaza 1/2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis
Vključevanje udeležencevFaza 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Vključevanje udeležencevFaza 3
- Clinical Study Site, Salt Lake City
- Clinical Study Site, Salt Lake City
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Vključevanje udeležencevFaza 1
- Huntsman Cancer Institute, Salt Lake City
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Vključevanje udeležencevFaza 1/2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1/2
- Utah Cancer Specialists, Salt Lake City
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- Utah Cancer Specialists, Salt Lake City
- University of Utah Health Huntsman Cancer Hospital, Salt Lake City
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- START Mountain Region, Salt Lake City
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Vključevanje udeležencevFaza 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
Vključevanje udeležencevFaza 1
- Huntsman Cancer Institute, Salt Lake City
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease
Vključevanje udeležencevFaza 2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Vključevanje udeležencevFaza 1/2
- Huntsman Cancer Institute, Salt Lake City
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Vključevanje udeležencevFaza 1/2
- Huntsman Cancer Institute, Salt Lake City
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Vključevanje udeležencevFaza 1/2
- START Center for Cancer Care - Mountain Region, Salt Lake City
JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
Vključevanje udeležencevFaza 1/2
- Huntsman Cancer Institute, Salt Lake City
ColoCare Study - Colorectal Cancer Cohort
Vključevanje udeležencevOpazovalna študija
- Huntsman Cancer Institute, Salt Lake City
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
Vključevanje udeležencevOpazovalna študija
- Utah Cancer Specialists, Salt Lake City
Študije za Kolorektalni rak v drugih mestih
- Houston, TX102 študij
- New York City, NY78 študij
- Nashville, TN69 študij
- Boston, MA63 študij
- Los Angeles, CA59 študij
- Arlington, VA52 študij
- St. Louis, MO50 študij
- San Antonio, TX46 študij
- Philadelphia, PA44 študij
- Grand Rapids, MI40 študij
- Baldwin Park, CA37 študij
- Chicago, IL34 študij
Druge študije v Salt Lake City
- Nemalicelični pljučni rak31 študij
- Rak (vse vrste)27 študij
- Rak dojke27 študij
- Rak pljuč21 študij
- Melanom21 študij
- Množni mielom21 študij
- Metastatski rak20 študij
- Rak jajčnikov19 študij
- Debelost18 študij
- Akutna mieločna levkemija17 študij
- Srčno popuščanje17 študij
- Rak prostate15 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.